Sage Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Sage Advisors's LLY Position: Q4 2025 in Review
Sage Advisors reduced its Eli Lilly (LLY) stake by 0.17% in Q4 2025, selling an estimated $31.6K and leaving 19,397 shares worth $20.8M. The position accounts for 13.82% of the portfolio, ranked #2.
Sage Advisors first reported a position in LLY in Q4 2023 and has held it in 9 quarters since. 4,428 funds tracked by Wall St. Rank hold LLY as of Q4 2025.
- Sage Advisors held 19,397 shares of Eli Lilly worth $20.8M as of Q4 2025.
- Sage Advisors sold 33 Eli Lilly shares in Q4 2025, an estimated $31.6K.
- Eli Lilly made up 13.82% of Sage Advisors's portfolio in Q4 2025, its #2 holding.
- Sage Advisors first reported a position in Eli Lilly in Q4 2023 and has held it in 9 quarters since.
- 4,428 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2025.
Based on Sage Advisors's 13F filing for Q4 2025, filed 13 Jan 2026.